Not_yet_recruitingNANCT07723053

A Prospective Randomized Controlled Trial of the Drum Tower Rule Machine Learning Model for Lowest Instrumented Vertebra Selection in Lenke Type 1 and Type 5 Adolescent Idiopathic Scoliosis

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Trial Details

ConditionAdolescent Idiopathic Scoliosis, Lenke Type 1 Adolescent Idiopathic Scoliosis, Lenke Type 5 Adolescent Idiopathic Scoliosis
InterventionDrum Tower Rule Machine Learning-Guided Decision Support; Conventional LIV Decision-Making; Posterior Spinal Fusion
PhaseNA
StatusNot_yet_recruiting
Participants300
Est. Completion1 June 2027
Last Updated23 July 2026

Primary Outcome

Incidence of Distal Adding-on

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Diagnosis of adolescent idiopathic scoliosis classified as Lenke type 1A or Lenke type 5C. * Age 10 to 18 years, inclusive. * Scheduled to undergo posterior spinal fusion using an all-pedicle screw instrumentation system. * Planned selective thoracic fusion or selective lumbar fusion, with a clinical need for lowest instrumented vertebra decision-making. * Availability of required preoperative standing full-spine radiographs and bending radiographs. * Ability and willingness to complete the planned 24-month postoperative follow-up. * Written informed consent provided by the participant and legal guardian. Exclusion Criteria: * \- Congenital scoliosis, neuromuscular scoliosis, syndromic scoliosis, or other non-idiopathic scoliosis. * History of spinal trauma, spinal tumor, spinal tuberculosis, or spinal infection. * Previous spinal surgery. * Severe sagittal spinal deformity, such as Scheuermann disease, for which the study model is not applicable. * Neurological symptoms or signs. * Leg length discrepancy greater than 10 mm. * The surgeon determines that there is no clinical equipoise for lowest instrumented vertebra selection because one option is clearly contraindicated for safety or anatomical reasons. * Inability to complete follow-up or required study assessments.

Trial Sites

Countries

China
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service